BIO-TECHNE Corp (TECH) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-28 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BIO-TECHNE Corp (TECH) CIK: 0000842023 --- Reporting Owner --- Name: Kelderman Kim CIK: 0001739054 Role: Director, Officer (Chief Executive Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-28 | Code: M (Exercise of derivative) Shares: +35,000 | Price: $47.60 Total Value: $1,666,000.00 Shares Owned After: 100,799 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-07-28 | Code: F (Payment of exercise/tax) Shares: -28,686 | Price: $72.07 Total Value: $2,067,400.02 Shares Owned After: 72,113 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-07-28 | Code: M (Exercise of derivative) Shares: -35,000 | Price: $0.00 Exercisable: N/A | Expires: 2026-08-07 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] Fully exercisable. --- Holdings --- [Holding #1] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #2] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #3] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #4] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F3] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F3] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #5] Security: Performance Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F3] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #6] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F4] Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. [Holding #7] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F5] Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. [Holding #8] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F3] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F3] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #9] Security: Performance Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F3] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #10] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F6] Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. [Holding #11] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F7] Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F7] Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #12] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F8] 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. [F8] 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. [Holding #13] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F9] Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. [Holding #14] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F10] Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F10] Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #15] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F11] 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. [F11] 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. [Holding #16] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F12] Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. --- Footnotes (Complete Index) --- F1: Fully exercisable. F10: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11: 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F12: Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F4: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F5: Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F6: Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F7: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8: 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F9: Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. --- Signature --- /s/ /s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed. (2026-07-30)